ArticleMedicine2026
Integrated bioinformatics and machine learning for constructing a diagnostic model of major depressive disorder leveraging shared signatures from hemodialysis: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a highly prevalent and debilitating condition in patients undergoing long-term hemodialysis (HD), severely impairing quality of life and imposing a substantial economic burden. Despite the clinical significance of this frequent co-occurrence, the shared molecular mechanisms linking HD and MDD remain poorly understood. Multiple gene expression omnibus transcriptomic datasets were integrated and preprocessed through standardized workflows to ensure comparability. Differentially expressed genes (DEGs) were identified separately for HD and MDD cohorts. Shared DEGs were subjected to functional enrichment analysis. A diagnostic model for MDD was constructed using machine learning algorithms based on the identified core genes. The model's performance was evaluated across the training cohort, external validation cohort, and subgroups. Additionally, immune cell infiltration patterns were analyzed, and associations between core genes and immune cells were assessed. Micro ribonucleic acid analysis identified potential upstream regulators of the core genes. A total of 34 DEGs were identified, which were significantly enriched in immune and inflammatory pathways. Using Lasso regression and gradient boosting algorithms, we identified 6 core genes (microsomal glutathione S-transferase 1 [MGST1], BAF chromatin remodeling complex subunit BCL7A [BCL7A], carnitine O-acetyltransferase [CRAT], fucosyltransferase 8 [FUT8], MAF BZIP transcription factor G [MAFG] and SDAD1 ribosome assembly factor [SDAD1]). In this exploratory analysis, the diagnostic model based on these genes exhibited consistent discriminative performance across different validation cohorts (area under the curve: 0.858-0.891). Immune infiltration analysis revealed significant alterations in immune phenotypes, particularly in monocytes and γδ T cells. Correlation analysis identified specific gene-immune associations. Furthermore, hsa-let-7b-5p was identified as a key upstream micro ribonucleic acid, which was upregulated in patients with MDD and exhibited predictive regulatory relationships with the core genes. This study established a molecular framework for MDD by integrating bioinformatics and machine learning, centered on the shared immune dysregulation and key genes between HD and MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.